Frank Litvack Capricor Therapeutics, Inc. (CAPR) insider trading activity

Frank Litvack is of CAPRICOR THERAPEUTICS, INC.. Currently has a direct ownership of 133,269 shares of CAPR, which is worth approximately $2.46 Million. The most recent transaction as insider was on Aug 14, 2023, when has been sold 4,364 shares (Common Stock) at a price of $6.61 per share, resulting in proceeds of $28,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

0% 3M change

0% 12M change

Total Value Held $2.46 Million

Frank Litvack Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2023	SELL Payment of exercise price or tax liability	$28,846 $6.61 p/Share	4,364 Reduced 3.17%	133,269 Common Stock
Aug 14 2023	BUY Exercise of conversion of derivative security	$28,839 $1.39 p/Share	20,748 Added 13.1%	137,633 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$19,498 $4.31 p/Share	4,524 Reduced 3.19%	137,276 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	$19,497 $1.39 p/Share	14,027 Added 9.0%	141,800 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$214,815 $3.18 p/Share	67,552 Reduced 38.62%	107,382 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$214,815 $1.39 p/Share	154,543 Added 46.91%	174,934 Common Stock

Frank Litvack

Beverly Hills, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CAPR shares.

Notify only if

Value

Insider Trading

Get notified when an Capricor Therapeutics, Inc. insider buys or sells CAPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to CAPRICOR THERAPEUTICS, INC.

Track Activities on CAPR

Account